View in EDS HTML Full Text PDF Full Text

Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway.

Saved in:
Bibliographic Details
Title: Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway.
Authors: Patel SR; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States., Lundgren TS; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.; Graduate Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory University School of Medicine, Atlanta, GA, United States., Baldwin WH; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States., Cox C; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States., Parker ET; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States., Healey JF; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States., Jajosky RP; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Zerra PE; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, Emory University School of Medicine, Atlanta, GA, United States., Josephson CD; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States., Doering CB; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States., Stowell SR; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Meeks SL; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.
Source: Frontiers in immunology [Front Immunol] 2022 May 11; Vol. 13, pp. 880829. Date of Electronic Publication: 2022 May 11 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35634288
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Patel+SR%22">Patel SR</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Lundgren+TS%22">Lundgren TS</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.; Graduate Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Baldwin+WH%22">Baldwin WH</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Cox+C%22">Cox C</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Parker+ET%22">Parker ET</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Healey+JF%22">Healey JF</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Jajosky+RP%22">Jajosky RP</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Zerra+PE%22">Zerra PE</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.; Center for Transfusion Medicine and Cellular Therapies, Department of Laboratory Medicine and Pathology, Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Josephson+CD%22">Josephson CD</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Doering+CB%22">Doering CB</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Stowell+SR%22">Stowell SR</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Meeks+SL%22">Meeks SL</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 May 11; Vol. 13, pp. 880829. <i>Date of Electronic Publication: </i>2022 May 11 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35634288
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2022.880829
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 880829
    Titles:
      – TitleFull: Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Patel SR
      – PersonEntity:
          Name:
            NameFull: Lundgren TS
      – PersonEntity:
          Name:
            NameFull: Baldwin WH
      – PersonEntity:
          Name:
            NameFull: Cox C
      – PersonEntity:
          Name:
            NameFull: Parker ET
      – PersonEntity:
          Name:
            NameFull: Healey JF
      – PersonEntity:
          Name:
            NameFull: Jajosky RP
      – PersonEntity:
          Name:
            NameFull: Zerra PE
      – PersonEntity:
          Name:
            NameFull: Josephson CD
      – PersonEntity:
          Name:
            NameFull: Doering CB
      – PersonEntity:
          Name:
            NameFull: Stowell SR
      – PersonEntity:
          Name:
            NameFull: Meeks SL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 05
              Text: 2022 May 11
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1